MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN)

CUSIP: 62855J104

Q2 2013 13F Holders as of 30 Jun 2013

Type / Class
Equity / Common Stock, par value $0.01 per share
Shares outstanding
93,057,750
Total 13F shares
945,393
Share change
-353,632
Total reported value
$25,403,266
Price per share
$26.87
Number of holders
8
Value change
-$9,000,267
Number of buys
4
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 62855J104?
CUSIP 62855J104 identifies MYGN - MYRIAD GENETICS INC - Common Stock, par value $0.01 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) as of Q2 2013

As of 30 Jun 2013, MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) was held by 8 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 945,393 shares. The largest 8 holders included WELLS FARGO & COMPANY/MN, PDT Partners, LLC, HUNTINGTON ASSET ADVISORS, INC., Northwest & Ethical Investments L.P., CITADEL ADVISORS LLC, Zurcher Kantonalbank (Zurich Cantonalbank), Conestoga Capital Advisors, LLC, and HUNTINGTON NATIONAL BANK. This page lists 8 institutional shareholders reporting positions in this security for the Q2 2013 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.